Financial reports
ARS
2023 FY
Annual report to shareholders
10 Apr 24
10-K
2023 FY
Annual report
9 Feb 24
10-Q
2023 Q3
Quarterly report
31 Oct 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
10-K
2022 FY
Annual report
9 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024
7 Feb 24
8-K
Other Events
13 Nov 23
8-K
Other Events
9 Nov 23
8-K
Neurocrine Biosciences Reports Third Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
31 Oct 23
8-K
Other Events
6 Oct 23
8-K
Other Events
5 Oct 23
8-K
Other Events
12 Sep 23
8-K
Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
1 Aug 23
8-K
Departure of Directors or Certain Officers
13 Jul 23
8-K
Departure of Directors or Certain Officers
11 Jul 23
Registration and prospectus
S-8
Registration of securities for employees
1 Aug 23
S-8
Registration of securities for employees
4 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Aug 20
S-8
Registration of securities for employees
3 Aug 20
S-8
Registration of securities for employees
5 Nov 19
S-8
Registration of securities for employees
22 Aug 18
S-8
Registration of securities for employees
14 Feb 18
S-3ASR
Automatic shelf registration
15 Feb 17
S-8
Registration of securities for employees
15 Feb 17
S-8
Registration of securities for employees
3 Aug 16
Proxies
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
DEFA14A
Additional proxy soliciting materials
1 May 23
DEFA14A
Additional proxy soliciting materials
5 Apr 23
DEF 14A
Definitive proxy
5 Apr 23
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEF 14A
Definitive proxy
7 Apr 22
DEFA14A
Additional proxy soliciting materials
9 Apr 21
DEF 14A
Definitive proxy
9 Apr 21
DEFA14A
Additional proxy soliciting materials
9 Apr 20
Other
CT ORDER
Confidential treatment order
18 Jan 22
CT ORDER
Confidential treatment order
30 Dec 21
UPLOAD
Letter from SEC
15 Nov 21
CORRESP
Correspondence with SEC
3 Nov 21
UPLOAD
Letter from SEC
27 Oct 21
CORRESP
Correspondence with SEC
5 Oct 21
UPLOAD
Letter from SEC
22 Sep 21
CT ORDER
Confidential treatment order
27 Sep 19
CT ORDER
Confidential treatment order
19 Mar 19
CT ORDER
Confidential treatment order
5 Jun 18
Ownership
4
ERIC BENEVICH
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
Ingrid Delaet
3 Apr 24
4
Ingrid Delaet
25 Mar 24
144
Notice of proposed sale of securities
21 Mar 24
4
ERIC BENEVICH
15 Mar 24
4
GEORGE J MORROW
15 Mar 24
4
RICHARD F POPS
15 Mar 24
4
Ingrid Delaet
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24